Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)

SHA:605199 Revenue

In the year 2025, Hainan Huluwa Pharmaceutical Group had annual revenue of 900.84M CNY, down -36.27%. Hainan Huluwa Pharmaceutical Group had revenue of 218.12M in the quarter ending December 31, 2025, a decrease of -42.75%.

• Revenue: 900.84M
• Revenue Growth: -36.27%
• P/S Ratio: 3.02
• Revenue / Employee: 428.36K
• Employees: 2,103
• Market Cap: 2.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	900.84M	-512.71M	-36.27%
Dec 31, 2024	1.41B	-381.64M	-21.26%
Dec 31, 2023	1.80B	280.14M	18.49%
Dec 31, 2022	1.52B	161.25M	11.91%
Dec 31, 2021	1.35B	192.09M	16.53%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error